Stocks and Investing
Stocks and Investing
Wed, August 28, 2024
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
[ Wed, Aug 28th 2024
] - WOPRAI
Kambiz Yazdi Initiated (ARQT) at Strong Buy and Held Target at $15 on, Aug 28th, 2024
Kambiz Yazdi of Jefferies, Initiated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $15 on, Aug 28th, 2024.
Kambiz has made no other calls on ARQT in the last 4 months.
There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Kambiz's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kambiz
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $18 on, Thursday, August 15th, 2024
- Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $18 on, Wednesday, May 15th, 2024
Contributing Sources